Used in the synthesis of pharmaceutical intermediates, particularly in the development of selective kinase inhibitors. Its chiral structure makes it valuable in asymmetric synthesis for active pharmaceutical ingredients (APIs) targeting neurological and inflammatory conditions. The fluorinated chromane core enhances metabolic stability and bioavailability in drug candidates. Commonly employed in research settings for optimizing lead compounds in medicinal chemistry programs.